ODC1
Basic information
Region (hg38): 2:10439968-10448327
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with alopecia and brain abnormalities (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with alopecia and brain imaging abnormalities (Bachmann-Bupp syndrome) | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dermatologic; Musculoskeletal; Neurologic | 30239107; 30475435 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ODC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 31 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 1 | 35 | 12 | 3 |
Variants in ODC1
This is a list of pathogenic ClinVar variants found in the ODC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-10440724-C-G | Uncertain significance (Oct 30, 2023) | |||
2-10440737-C-G | Uncertain significance (May 13, 2023) | |||
2-10440765-G-A | Inborn genetic diseases | Likely benign (Apr 26, 2024) | ||
2-10440768-T-A | Neurodevelopmental disorder with alopecia and brain abnormalities | Pathogenic (Jan 05, 2021) | ||
2-10440774-C-T | Likely benign (Sep 01, 2022) | |||
2-10440786-C-T | Uncertain significance (Mar 30, 2023) | |||
2-10440793-CACAG-C | Neurodevelopmental disorder with alopecia and brain abnormalities | Likely pathogenic (Jun 07, 2020) | ||
2-10440798-G-A | Uncertain significance (Mar 29, 2023) | |||
2-10440829-G-A | Likely benign (Feb 01, 2024) | |||
2-10440840-C-T | Neurodevelopmental disorder with alopecia and brain abnormalities | Uncertain significance (Mar 26, 2021) | ||
2-10440841-G-A | Benign (Jun 22, 2018) | |||
2-10440846-TCTGGAATTGCTGCATGAGTTGC-T | Neurodevelopmental disorder with alopecia and brain abnormalities | Pathogenic (Jan 05, 2021) | ||
2-10440855-G-A | Neurodevelopmental disorder with alopecia and brain abnormalities | Pathogenic (Jan 05, 2021) | ||
2-10440858-G-A | Likely pathogenic (Aug 24, 2023) | |||
2-10440870-T-C | Pathogenic (Oct 19, 2020) | |||
2-10441507-A-C | Inborn genetic diseases | Uncertain significance (May 21, 2024) | ||
2-10441508-C-A | Neurodevelopmental disorder with alopecia and brain abnormalities | Pathogenic (Jan 05, 2021) | ||
2-10441508-C-CCA | Neurodevelopmental disorder with alopecia and brain abnormalities | Pathogenic (Jan 05, 2021) | ||
2-10441512-G-A | Inborn genetic diseases | Uncertain significance (Oct 20, 2023) | ||
2-10441521-G-A | Uncertain significance (Mar 12, 2022) | |||
2-10441533-T-A | ODC1-related disorder | Uncertain significance (Sep 07, 2023) | ||
2-10441539-G-A | Uncertain significance (Nov 03, 2021) | |||
2-10441563-G-A | Neurodevelopmental disorder with alopecia and brain abnormalities | Uncertain significance (Aug 12, 2021) | ||
2-10441588-C-T | Uncertain significance (Apr 19, 2021) | |||
2-10441589-G-A | Likely benign (Apr 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ODC1 | protein_coding | protein_coding | ENST00000234111 | 10 | 8537 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.170 | 0.830 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.47 | 209 | 278 | 0.752 | 0.0000157 | 3064 |
Missense in Polyphen | 41 | 80.268 | 0.51079 | 1027 | ||
Synonymous | -0.946 | 118 | 106 | 1.12 | 0.00000664 | 862 |
Loss of Function | 3.02 | 5 | 19.4 | 0.258 | 8.12e-7 | 260 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000337 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the first and rate-limiting step of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine. Polyamines are essential for cell proliferation and are implicated in cellular processes, ranging from DNA replication to apoptosis. {ECO:0000269|PubMed:17900240}.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Glutathione metabolism - Homo sapiens (human);Spermidine and Spermine Biosynthesis;Integrated Breast Cancer Pathway;Methionine De Novo and Salvage Pathway;Amino Acid metabolism;Urea cycle and metabolism of amino groups;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives;putrescine biosynthesis I;Metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Arginine Proline metabolism;Validated targets of C-MYC transcriptional activation
(Consensus)
Recessive Scores
- pRec
- 0.398
Intolerance Scores
- loftool
- 0.147
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24.33
Haploinsufficiency Scores
- pHI
- 0.269
- hipred
- Y
- hipred_score
- 0.654
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Odc1
- Phenotype
- embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- odc1
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- kidney development;regulation of cellular amino acid metabolic process;polyamine metabolic process;positive regulation of cell population proliferation;response to virus;putrescine biosynthetic process from ornithine;regulation of protein catabolic process
- Cellular component
- cellular_component;cytoplasm;cytosol;perinuclear region of cytoplasm
- Molecular function
- ornithine decarboxylase activity;protein binding;protein homodimerization activity